Sangel Capital
Venture capitalShenzhen · Seed–Late Stage
Find your way into Sangel Capital
Investment thesis
Sangel Venture concentrates on the life science and technology sector, positioning itself as one of China's earliest professional biomedical venture investors. Drawing on deep industry expertise and project resources, it identifies innovative growth-stage enterprises with strong capital value and commercial potential, aiming to build benchmark companies across subdivided segments of the biomedical industry. The firm assembles investment and advisory teams of industry experts, scientists, and investors in life technology to manage a series of both RMB- and USD-denominated funds.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 6 of 13 portfolio companiesBiotech ×6Healthtech ×4Medical Devices ×4Digital Health ×2Advanced Manufacturing ×1AI & Machine Learning ×1B2B Marketplaces ×1Deep Tech ×1
HQs:China×2United States×2
Investments · 13 tracked
founders shown can be your intro path
Beyond Spring Pharmaceuticals develops Plinabulin, a brain-penetrant immune modulator that activates dendritic cells through a differentiated tubulin-binding mechanism, intended to enhance antigen presentation and T cell activation for select tumor types.
BiotechHealthtechMedical Devices
Co-investorsDecheng Capital
Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)Rob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in
Co-investorsARCH Venture PartnersNorthpond Ventures6 Dimensions CapitalAlly Bridge GroupApplied VenturesKilonova Capital+3 more
KBP Biosciences is a biotechnology research and development organization that discovers and develops innovative therapeutic drugs for unmet medical needs using an integrated discovery and development platform.
Biotech
Shanghai Jizhi Biochemical is a reagent company specializing in the research and development of biochemical reagents and life science products.
Advanced ManufacturingB2B MarketplacesBiotechE-commerceHangzhou, CN
A research-driven specialty pharmaceutical company that develops and commercializes innovative medicines through the 505(b)(2) regulatory pathway, focusing on central nervous system disorders, metabolic diseases, and orphan indications.
BiotechDigital HealthHealthtechMedical DevicesNew Jersey, US
Shoufeng Li(Chief Executive Officer)
Uni-medica develops automated fluorescence staining and analysis systems, nucleic acid detection kits, and high-throughput sequencing products for molecular diagnostic applications including cervical cancer screening, pathogen detection, and genetic disease identification.
BiotechDigital HealthHealthtechMedical DevicesShenzhen, CN
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
LamtherapeuticsVersaeutics喜鹊医药宝来通思路迪艾欣达伟苏州沪云
Portfolio news
latest coverage across their companiesBeyondSpring Pharmaceuticals · themarketsdaily.com · Jul 29, 2026
Frequently asked questions
- How many investments has Sangel Capital made?
- Sangel Capital has 13 tracked investments, 1 of which have exited.
- What stage does Sangel Capital invest at?
- Sangel Capital invests at the Seed, Series A, Growth, Late Stage stages.
- What sectors does Sangel Capital focus on?
- Sangel Capital focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Sangel Capital located?
- Sangel Capital is headquartered in Shenzhen, CN.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
Gore Range Capital is a specialized healthcare investment firm building science-led platforms across precision health, regenerative medicine, personalized therapeutics, and longevity. It provides strategic, financial, and clinical guidance to portfolio companies developing next-generation healthcare solutions.